L773:0174 1551
Sökning: L773:0174 1551 > (2015-2019) > Primary Stenting of...
- 6 av 6
- Föregående post
- Nästa post
- Till träfflistan
- Lindgren, Hans I.V.Lund University,Lunds universitet,Kliniska Vetenskaper, Helsingborg,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Vaskulära sjukdomar - kliniska studier,Forskargrupper vid Lunds universitet,Clinical Sciences, Helsingborg,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Vascular Diseases - Clinical Research,Lund University Research Groups,Helsingborg Hospital (författare)
Primary Stenting of the Superficial Femoral Artery in Patients with Intermittent Claudication Has Durable Effects on Health-Related Quality of Life at 24 Months: Results of a Randomized Controlled Trial
- Artikel/kapitelEngelska2018
Förlag, utgivningsår, omfång ...
- 2018-03-08
- Springer Science and Business Media LLC,2018
Nummerbeteckningar
- LIBRIS-ID:oai:gup.ub.gu.se/268749
- https://gup.ub.gu.se/publication/268749URI
- https://doi.org/10.1007/s00270-018-1925-0DOI
- https://lup.lub.lu.se/record/350cbd1b-cbe7-47e1-91cd-34d2964443a6URI
Kompletterande språkuppgifter
- Språk:engelska
Ingår i deldatabas
- SwePubSwePub
Klassifikation
Anmärkningar
- Background Intermittent claudication (IC) is commonly caused by lesions in the superficial femoral artery (SFA), yet invasive treatment is still controversial and longer term patient-reported outcomes are lacking. This prospective randomized trial assessed the 24-month impact of primary stenting with nitinol self-expanding stents compared to best medical treatment (BMT) alone in patients with stable IC due to SFA disease on health-related quality of life (HRQoL). Methods One hundred patients with stable IC due to SFA disease treated with BMT were randomized to either stent (n = 48) or control (n = 52) group. HRQoL assessed by Short Form 36 Health Survey (SF-36) and EuroQoL 5-dimensions (EQ5D) 24 months after treatment were primary outcome measures. Walking Impairment Questionnaire, ankle-brachial index (ABI), and walking distance were secondary outcomes. Results Significantly better SF-36 Physical Component Summary (P = 0.024) and physical domain scores such as Physical Function (P = 0.012), Bodily Pain (P = 0.002), General Health (P = 0.037), and EQ5D (P = 0.010) were reported in intergroup comparison between the stent and the control group. Both ABI (from 0.58 +/- 0.11 to 0.85 +/- 0.18; P < 0.001 in the stent group and from 0.63 +/- 0.17 to 0.69 +/- 0.18; P = 0.036 in the control group) and walking distance (from 170 +/- 90 m to 616 +/- 375 m; P < 0.001 in the stent group and from 209 +/- 111 m to 331 +/- 304 m; P = 0.006 in the control group) improved significantly in intragroup comparisons. Conclusions In patients with IC caused by lesions in the SFA, primary stenting compared to BMT alone was associated with significant improvements in HRQoL, ABI, and walking distance durable up to 24 months of follow-up.
Ämnesord och genrebeteckningar
- MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Kardiologi hsv//swe
- MEDICAL AND HEALTH SCIENCES Clinical Medicine Cardiac and Cardiovascular Systems hsv//eng
- MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Radiologi och bildbehandling hsv//swe
- MEDICAL AND HEALTH SCIENCES Clinical Medicine Radiology, Nuclear Medicine and Medical Imaging hsv//eng
- Peripheral arterial disease
- Intermittent claudication
- Primary stenting
- Health-related quality of life
- percutaneous transluminal angioplasty
- paclitaxel-eluting stents
- supervised exercise
- clinical-trial
- follow-up
- femoropopliteal artery
- balloon angioplasty
- coated balloon
- disease
- revascularization
- Cardiovascular System & Cardiology
- Radiology
- Medical Imaging
- Superficial femoral artery
Biuppslag (personer, institutioner, konferenser, titlar ...)
- Qvarfordt, PeterHelsingborg Hospital(Swepub:lu)med-pqf (författare)
- Bergman, StefanLund University,Lunds universitet,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa,Institute of Medicine, School of Public Health and Community Medicine,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Spenshult Research and Development Center,Sahlgrenska Academy(Swepub:lu)med-seb (författare)
- Gottsäter, AndersLund University,Lunds universitet,Vaskulära sjukdomar - kliniska studier,Forskargrupper vid Lunds universitet,Vascular Diseases - Clinical Research,Lund University Research Groups,Skåne University Hospital(Swepub:lu)medf-ago (författare)
- Kliniska Vetenskaper, HelsingborgSektion II (creator_code:org_t)
- Swedish Endovascular Claudication Stenting Trialists
Sammanhörande titlar
- Ingår i:Cardiovascular and Interventional Radiology: Springer Science and Business Media LLC41:6, s. 872-8810174-15511432-086X
Internetlänk
Hitta via bibliotek
- Cardiovascular and Interventional Radiology (Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- 6 av 6
- Föregående post
- Nästa post
- Till träfflistan
Hitta mer i SwePub
- Av författaren/redakt...
- Lindgren, Hans I ...
- Qvarfordt, Peter
- Bergman, Stefan
- Gottsäter, Ander ...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Kardiologi
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Radiologi och bi ...
- Artiklar i publikationen
- Cardiovascular a ...
- Av lärosätet
- Göteborgs universitet
- Lunds universitet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
